Log in to save to my catalogue

Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center ex...

Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center ex...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9b7f1d1554de4916904fb600cac6c367

Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience

About this item

Full title

Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience

Publisher

England: BioMed Central Ltd

Journal title

Journal for immunotherapy of cancer, 2019-01, Vol.7 (1), p.2-13, Article 2

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

The approved therapeutic indication for immune checkpoint inhibitors (CPIs) are rapidly expanding including treatment in the adjuvant setting, the immune related toxicities associated with CPI can limit the efficacy of these agents. The literature on the nephrotoxicity of CPI is limited. Here, we present cases of biopsy proven acute tubulointerstit...

Alternative Titles

Full title

Nephrotoxicity of immune checkpoint inhibitors beyond tubulointerstitial nephritis: single-center experience

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9b7f1d1554de4916904fb600cac6c367

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9b7f1d1554de4916904fb600cac6c367

Other Identifiers

ISSN

2051-1426

E-ISSN

2051-1426

DOI

10.1186/s40425-018-0478-8

How to access this item